Abstract
To determine the factor triggering the sudden surge of daily new COVID-19 cases arising in most European countries during the autumn of 2020. The dates of the surge were determined using a fitting of the two last months of reported daily new cases in 18 European countries with latitude ranging from 39° to 62°. The study proves no correlation between the country surge date and the 2 weeks preceding temperature or humidity but shows an impressive linear correlation with latitude. The country surge date corresponds to the time when its sun UV daily dose drops below ≈ 34% of that of 0° latitude. Introducing reported seasonal blood 25-hydroxyvitamin D (25(OH)D) concentration variation into the reported link between acute respiratory tract infection risk and 25(OH)D concentration quantitatively explains the surge dynamics. Several studies have already substantiated a 25(OH)D concentration impact on COVID-19 severity. However, by comparing different patient populations, discriminating whether a low 25(OH)D concentration is a real factor underlying COVID-19 severity or only a marker of another weakness that is the primary severity factor can be challenging. The date of the surge is an intrapopulation observation and has the benefit of being triggered only by a parameter globally affecting the population, i.e. decreases in the sun UV daily dose. The results indicate that a low 25(OH)D concentration is a contributing factor to COVID-19 severity, which, combined with previous studies, provides a convincing set of evidence.
Subject terms: Viral infection, Health policy
Introduction
Most European countries underwent an unexpected surge of daily new COVID-19 cases in autumn (Fig. 1), imposing new confinement rules and emergency lockdowns.
A commonly reported explanation is the decreasing temperature. The aim of this study is to challenge this assumption against a pure latitude impact.
Materials and methods
Data sources
The countries’ daily new COVID-19 cases, more exactly, the daily new SARS-CoV-2 seropositive cases, were obtained from the European Union agency European Centre for Disease Prevention and Control (https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide).
The country population weighted centre (PWC) latitudes were obtained from the Baylor University population resource (http://cs.ecs.baylor.edu/~hamerly/software/europe_population_weighted_centers.txt).
The averaged 2-week temperatures and humidity preceding the surge dates were computed from https://rp5.ru, which collects the archives of all airport weather stations in the world. For each country, an airport close to the PWC was chosen (see supplementary Excel file). The average temperature and humidity were computed between 8h00 to 20h00, outside this period, the population is mostly indoors.
School opening dates of 15 out of the 18 countries studied were found at https://eacea.ec.europa.eu/national-policies/eurydice/sites/eurydice/files/school_calendar_2020_21_0.pdf.
The theoretical sun UVB daily dose for vitamin D production, as a function of latitude and of the day of the year, was derived from the digitalization of Fig. 1B from reference1.
The reinforcement dates of the safety measure were obtained from the Public Health and Social Measures (PHSM) index of the WHO at https://who.maps.arcgis.com/apps/opsdashboard/index.html#/ead3c6475654481ca51c248d52ab9c61.
All these data are in the supplementary Excel file.
Surge date determination
The date of the surge was automatically determined by fitting the two last months of the daily new COVID-19 cases with the empirical model:
1 |
where is the logistic function:
2 |
is the date when the exponential coefficient, coming from the initial value , crosses the value before tending towards the final value when . is the steepness of this changing. The date of the surge was defined as the time when 10% of was added to ; this choice corresponds to the date when Eq. (1) visually becomes different from the monoexponential (see supplementary file). was assumed to be country independent, as we searched for an impact of latitude on its own. This further allows us to prevent overfitting of the data noise by a steepness tuned for each country.
Note that as the exponential coefficient varies with time, the doubling time around the surge date is not simply ln(2) divided by this coefficient.
Dynamic models of new daily cases
To evaluate the impact of UV insolation on the new daily case dynamics, we consider the simple model:
3 |
where is the total number of persons who have active SARS-CoV-2 at time t, its derivative is the new daily cases, and is the mean effective contagiousness of an infected subject, which mainly depends on his coronavirus release in air and on materials, on the closeness and frequency of his contacts with other subjects; ρ is the recovery rate.
The solution of Eq. (3) is:
4 |
where Nc is the initial number of infected persons in country c.
If the contagiousness is constant, the daily new cases follow a monoexponential increase or decrease:
5 |
We will consider two impacts of UV insolation: outdoor SARS-CoV-2 inactivation and blood 25-hydroxyvitamin D (25(OH)D) concentration.
Impact of outdoor SARS-CoV-2 inactivation by solar UV
The active fraction survival of SARS-CoV-2 f. under a constant UV insolation R is governed by:
6 |
where α is the solar UV sensitivity of SARS-CoV-2, and τ is the insolation duration. A recent detailed analysis2 shows that in Europe, τ90, i.e. the noon solar insolation duration needed to inactivate 90% of SARS-CoV-2, approximatively linearly increases between August and October from 60 to 150 min for southern countries and from 100 to 250 min for northern countries.
Considering this inactivation as the single effect varying k(t), we obtain:
7 |
where is the mean time between the infection of a material and the contact with this material by a noninfected person.
Figure 2A shows a typical k1(t) curve for τ90 ranging from 60 to 250 min, and = 30 min ( can be modified in the supplementary Excel file) and figure 2C its corresponding daily new cases (Eq. 4).
Impact of blood (25(OH)D) concentration
A meta-analysis of 24 studies reporting the association between 25(OH)D concentration and the risk or severity of acute respiratory track infection (ARTI) during cold or influenza epidemics3 shows that the risk follows a power-exponential relation (Fig. 2B).
Assuming that COVID-19 risk similarly depends on 25(OH)D concentration and considering this risk increase as the single effect varying k(t), we obtain
8 |
where D(t) is the 25(OH)D concentration expressed in nmol/L units at time t.
Figure 2D shows the corresponding daily new case (Eq. 4).
Studies in Europe4–8 reported a seasonal 25(OH)D concentration drop of 20–26% between August and October (Table 1). Two longitudinal studies6,7 followed one single cohort over 12 months, with one7 reporting the 25(OH)D concentration curves for each subject allowing a rough estimation of the intraindividual standard deviation, giving a drop of 26 ± 25% in normal subjects (age 31 ± 3 years). This standard deviation could still be higher in the country population with the presence of older and chronically ill subjects. As a result, more than 15% of the European active population could suffer from a 25(OH)D concentration decrease larger than 50% from August to October. Assuming that the COVID-19 risk follows Fig. 2B and that the whole population has an initial D = 90 nmol/L value, a rough estimation of the k(t) surge can be computed (see Excel sheet “vitD severity” S-AA for the numerical integration result) as:
9 |
Table 1.
Country (ref) | PWC lat. (deg) | Population | Type | n ± std per month | Age (year) | Drop ± std (%) |
---|---|---|---|---|---|---|
Sweden4 | 59.0 | Blood donors | ≠ cohorts | 45 ± 9 | 41 ± 13 | 22 |
Denmark5 | 55.9 | Blood donors | ≠ cohorts | 16 ± ? | 24–89 | 23 |
UK6 | 52.8 | 1958 birth | Longitudinal | 6789 | 45 ± 0 | 26 ± ? |
Netherland7 | 52.1 | Nurses | Longitudinal | 8 | 31 ± 3 | 26 ± 25 |
Poland8 | 51.7 | Athletes | ≠ cohorts | 229 ± 55 | 25 ± 1 | 23 |
Right column: 25(OH)D concentration drop between August and November.
In the integral, but due to the higher exponential power of the Gaussian distribution, i.e. 2, versus that of k(D), i.e. 1.6, the integral does not diverge and can even be truncated at D = 0. The integration was extended above the initial D = 90 nmol/L value because one patient in the cohort7 exhibited a concentration increase rather than a drop.
Results
Table 2 shows the fitting results (all data and fitting processes are provided in the supplementary xlsx file). For Sweden, the new daily cases were constant before August, preventing the computation of the β/α ratio. Although that the parameters are accurately measured, they suffer from the limitations that, besides the latitude, they are not population weighted.
Table 2.
Country | School opening | Temp (°C) | Hum (%) | PWC lat (deg) | Surge start | Day | Solar UV (%) | β/α | |
---|---|---|---|---|---|---|---|---|---|
Greece | 23 | 52 | 38.7 | Oct 21 | 295 | 37 | 1.21 | ||
Portugal | Sept 14 | 18 | 79 | 39.7 | Oct 10 | 284 | 41 | 1.06 | |
Spain | 18 | 47 | 39.8 | Oct 14 | 289 | 39 | 1.37 | ||
Bulgaria | Sept 14 | 22 | 55 | 42.8 | Oct 06 | 281 | 39 | 1.16 | |
Italy | Sept 14 | 20 | 70 | 42.9 | Oct 06 | 281 | 39 | 1.02 | |
Serbia | Sept 01 | 15 | 72 | 43.8 | Oct 18 | 293 | 32 | 1.13 | |
Croatia | Sept 01 | 17 | 68 | 45.3 | Oct 10 | 284 | 34 | 1.06 | |
Slovenia | Sept 01 | 13 | 83 | 46.2 | Oct 12 | 286 | 32 | 1.17 | |
Switzerland | Aug 17 | 14 | 78 | 47.0 | Oct 04 | 279 | 34 | 1.25 | |
France | Sept 01 | 14 | 80 | 47.2 | Oct 11 | 286 | 31 | 1.09 | |
Austria | Sept 08 | 13 | 71 | 47.8 | Oct 16 | 290 | 28 | 1.10 | |
Belgium | Sept 01 | 21 | 53 | 50.8 | Sept 25 | 270 | 34 | 1.02 | |
Germany | Aug 14 | 14 | 73 | 50.9 | Oct 06 | 281 | 29 | 1.15 | |
Netherland | Sept 01 | 18 | 66 | 52.1 | Sept 26 | 271 | 32 | 1.08 | |
UK | Sept 01 | 18 | 67 | 52.8 | Sept 19 | 263 | 35 | 1.14 | |
Russia | 18 | 59 | 54.3 | Sept 13 | 258 | 37 | 1.06 | ||
Sweden | Sept 01 | 15 | 72 | 59.0 | Sept 13 | 258 | 30 | ||
Finland | Aug 14 | 15 | 73 | 61.8 | Sept 10 | 254 | 27 | 1.11 |
PWC lat latitude of the country PWC, Sun UV theoretical sun UV daily dose at the surge date, expressed as a fraction at the PWC latitude versus the latitude 0°.
Table 3 shows the reinforcement implemented during September and October of the existing safety measures (see country pages in Excel file to see the intensity level of each safety measure). With regard to the delay between infection and contagiousness of a subject, only two reinforcements (in bold) could have delayed the surge date. The abundance of measured reinforcements within the two weeks following the surge date provides evidence of the surge threat.
Table 3.
Country | Surge start | Mask | Schools | Work | Gathering | Movement | Int. travel | |
---|---|---|---|---|---|---|---|---|
Greece | Oct 21 | Oct 16 | ||||||
Portugal | Oct 10 | Oct 22 | Oct 22 | |||||
Spain | Oct 14 | Oct 14 | Oct 02 | |||||
Bulgaria | Oct 06 | Oct 27 | Oct 06 | Oct 06 | Oct 04 | |||
Italy | Oct 06 | Oct 05 | Oct 13 | Oct 22 | ||||
Serbia | Oct 18 | |||||||
Croatia | Oct 10 | Oct 27 | ||||||
Slovenia | Oct 12 | Oct 20 | Oct 20 | Oct 17 | Oct 17 | |||
Switzerland | Oct 04 | Oct 25 | Oct 22 | Oct 22 | Oct 22 | |||
France | Oct 11 | Sept 10 | Oct 27 | Oct 27 | Oct 27 | |||
Austria | Oct 16 | Oct 15 | Oct 15 | Oct 15 | Oct 15 | |||
Belgium | Sept 25 | Oct 05 | Oct 15 | Oct 15 | ||||
Germany | Oct 06 | Oct 20 | Oct 20 | Oct 12 | Oct 20 | |||
Netherland | Sept 26 | Oct 15 | Sept 29 | Oct 14 | ||||
UK | Sept 19 | Oct 20 | Oct 07 | Sept 12 | Sept 20 | |||
Russia | Sept 13 | Oct 15 | Oct 02 | Oct 05 | Oct 11* | |||
Sweden | Sept 13 | Oct 27 | ||||||
Finland | Sept 10 | Sept 30 | Oct 22 | Oct 12 |
Bold: reinforcement could have reduced the surge.
*Decrease of the safety measure.
Figure 3A,B clearly prove no correlation with temperature or humidity, while Fig. 3C clearly shows an impact of country latitude.
Figure 4 clearly shows that the surge dates set on the sun UVB daily dose as a function of latitude demonstrate an impact of the sun UVB daily dose.
Figure 5 shows that the day of the second wave surge is predicted well by the time when the sun UVB daily dose of the country becomes lower than 30% of that at latitude 0°.
Discussion
Many studies support an impact of low 25(OH)D concentrations on respiratory impairment in coronavirus or viral diseases9 and recently on the COVID-19 pandemic as well (see10 for a detailed review and analysis of 14 studies reporting such impacts). Low 25(OH)D concentrations are also more prevalent in populations at risk, i.e. aged people11,12, obese patients13, people with coloured skin living in high latitude countries14 and diabetic patients15.
However, by comparing COVID-19 severity between different populations, determining whether the 25(OH)D concentration is a real factor of COVID-19 severity or only a marker of another weakness that is the primary severity factor can be challenging.
The date of the surge is an intrapopulation observation and has the benefit of being triggered only by a parameter globally affecting this population. There is no correlation with temperature, humidity, or school opening dates (see Excel file), but there is an impressive latitude correlation (Fig. 3). The remaining common parameter affecting these populations monotonically at different times depending on latitude is the sun UV daily dose (Fig. 4).
This UV index dependence was already observed for influenza epidemics16, although the temperature dependence appeared more important. A global seasonality study also evidenced a monthly correlation between other pre-existing human seasonal coronavirus activities and temperature and humidity17. However, this study did not consider latitude as a confounding factor, and on a monthly scale, there is a correlation between temperature-humidity and latitude. On the daily scale used in the present study, this correlation no longer exists as each country is temporally affected by different wind directions. This feature allows us to clearly discriminate between temperature-humidity and latitude impacts.
Decreasing sun UV insolation can impact COVID-19 dynamics in two ways: by decreasing outdoor SARS-CoV-2 inactivation or by decreasing the population 25(OH)D concentration.
However, many European countries were able to break the surge in November by implementing additional safety rules. Activities where people cannot wear face masks, such as collective sports or relaxation in pubs and restaurants, were forbidden, and festive activities where people often forget distancing recommendations were forbidden. In contrast, the population continued their professional and outdoor relaxing activities wearing face masks at work, in public transport, in itinerant outdoor markets (European use) and in parks. The success of these rules supports the major role of airborne transport of SARS-CoV-2 versus contamination by outdoor contact with infected material.
Equations (7, 8) clearly illustrate that the potential impacts on COVID-19 dynamics of outdoor SARS-CoV-2 inactivation and a decrease in 25(OH)D concentration are fundamentally different. Indeed, Fig. 2B indicates that even if the 25(OH)D concentration slowly decreased after the summer solstice, its impact on contagiousness becomes increasingly important with time and leads the dynamics to strongly diverge from a monoexponential trend after a while as shown in Fig. 2D, which is in line with the data in October. In contrast, Fig. 2A indicates that the impact of outdoor SARS-CoV-2 inactivation decrease on COVID-19 contagiousness becomes increasingly less important with time, which should correspond to an increase in July–September, moving towards a doubling time stabilisation, as shown in Fig. 2C.
Another feature discards the potential role of solar UV inactivation: in Europe, people spend the majority of their time indoors, so even if contact with a contaminated surface can be a source of transmission, the contact probability is lower outdoors than indoors where solar UV inactivation is absent. This is in line with a one week recent study showing that outdoor contamination is much less frequent than indoor ones18.
The obtained β/α ratios range from 1.02 to 1.37 (Table 2), which is in line with the estimated ratio of 1.18 as Eq. (9) neglects any country dependence and was based on a small cohort (n = 8) follow-up.
The positive linear slope of the sun UVB threshold versus the country latitude (Fig. 4) is also in line with the fact that, due to natural adaptation, populations have increasingly pigmented skin when the latitude decreases. As a result, skin vitamin D production in northern populations is affected by the sun UVB decrease in a slower manner than that of the southern populations. Figure 4 is also in line with the low population mortality observed within ± 35° latitudes19 and reported in Hubei located at 31° latitude, because these regions are above the sun UV daily dose 34% average threshold most of the year.
The present study thus suggests that a low 25(OH)D concentration is a contributing factor of COVID-19 severity, as already shown by previous studies10, which together constitute a convincing bundle of evidence. By increasing the coronavirus load in the respiratory tract, the contagiousness in the population is also increased, starting a chain reaction that explains the wave surge.
This study has three strengths. The utilisation of the date of the surge is not dependent on the differences between the safety measures implemented in the countries but can only depend on the change in a global parameter affecting the whole country population. The correlation analysis on a daily scale prevents the interpretation from being blurred by the seasonal latitude-climate correlation existing on a monthly scale. Using the relation reported between ARTI and 25(OH)D concentration together with the reported seasonal 25(OH)D concentration variation, the derived prediction of the daily new case slope increase is in line with the observation.
The study has several weakness. Some countries have a homogeneous population distributed at a few latitudes, such as France, Germany, and Russia, which could twist or blur the correlation. Access to reported regional new daily cases should be very valuable. The surge intensity analysis was performed using the 25(OH)D concentration reported in a small volunteer cohort. Observed autumn 25(OH)D concentration decrease for several countries should be helpful to further increase the confidence in the vitamin D status contribution.
Conclusion
As already evidenced by previous correlation studies10, a low 25(OH)D concentration should be considered a contributing factor to COVID-19 severity.
Europe and the northern USA are starting a long COVID-19 crisis this autumn, as they will return to a level above the October sun UV daily dose only at the end of March 2021.
Measures to reduce the pandemic severity during the coming winter using controlled preventive vitamin D supplementation should be considered10,20.
Supplementary Information
Author contributions
S.W. is the single contributor.
Competing interests
The author declares no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-021-81419-w.
References
- 1.Grigalavicius M, Juzeniene A, Baturaite Z, Dahlback A, Moan J. Biologically efficient solar radiation: Vitamin D production and induction of cutaneous malignant melanoma. Dermato-endocrinology. 2013;5:150–158. doi: 10.4161/derm.22941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Herman J, Biegel B, Huang L. Inactivation times from 290 to 315 nm UVB in sunlight for SARS coronaviruses CoV and CoV-2 using OMI satellite data for the sunlit Earth. Air Qual. Atmos. Health. 2020;1:1–7. doi: 10.1007/s11869-020-00927-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Pham H, Rahman A, Majidi A, Waterhouse M, Neale RE. Acute respiratory tract infection and 25-hydroxyvitamin D concentration: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2019;16:3020. doi: 10.3390/ijerph16173020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Klingberg E, Oleröd G, Konar J, Petzold M, Hammarsten O. Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort. Endocrine. 2015;49:800–808. doi: 10.1007/s12020-015-0548-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Moosgaard B, et al. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin. Endocrinol. 2005;63:506–513. doi: 10.1111/j.1365-2265.2005.02371.x. [DOI] [PubMed] [Google Scholar]
- 6.Berry DJ, Hesketh K, Power C, Hyppönen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br. J. Nutr. 2011;106:1433–1440. doi: 10.1017/S0007114511001991. [DOI] [PubMed] [Google Scholar]
- 7.Juttmann JR, Visser TJ, Buurman C, De Kam E, Birkenhäger JC. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br. Med. J. 1981;282:1349–1352. doi: 10.1136/bmj.282.6273.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Krzywanski J, et al. Seasonal vitamin D status in Polish elite athletes in relation to sun exposure and oral supplementation. PLoS ONE. 2016;11:e0164395. doi: 10.1371/journal.pone.0164395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Martineau AR, et al. Vitamin D supplementation to prevent acute respiratory infections: Individual participant data meta-analysis. Health Technol. Assess. 2019;23:1–44. doi: 10.3310/hta23020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Mercola J, Grant WB, Wagner CL. Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients. 2020;12:3361. doi: 10.3390/nu12113361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am. J. Clin. Nutr. 2007;85:860–868. doi: 10.1093/ajcn/85.3.860. [DOI] [PubMed] [Google Scholar]
- 12.Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin. Exp. Res. 2020;6:1–4. doi: 10.1007/s40520-020-01570-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Carter SJ, Baranauskas MN, Fly AD. Considerations for obesity, vitamin D, and physical activity amid the COVID-19 pandemic. Obesity. 2020;28:1176–1177. doi: 10.1002/oby.22838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Boucher BJ. Vitamin D status as a predictor of Covid-19 risk in Black, Asian and other ethnic minority groups in the UK. Diabetes/Metab. Res. Rev. 2020;1:3375. doi: 10.1002/dmrr.3375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Payne J, et al. Vitamin D insufficiency in diabetic retinopathy. Endocr. Pract. 2012;18:185–193. doi: 10.4158/EP11147.OR. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ianevski A, et al. Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010–2018. Viruses. 2019;11:207. doi: 10.3390/v11030207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Li Y, Wang X, Nair H. Global seasonality of human seasonal coronaviruses: A clue for postpandemic circulating season of severe acute respiratory syndrome coronavirus 2? J. Infect. Dis. 2020;222:1090–1097. doi: 10.1093/infdis/jiaa436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bulfone TC, Malekinejad M, Rutherford GW, Razani N. Outdoor transmission of SARS-CoV-2 and other respiratory viruses, a systematic review. J. Infect. Dis. 2020;222:1090–1097. doi: 10.1093/infdis/jiaa436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rhodes JM, Subramanian S, Laird E, Kenny RA. low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment. Pharmacol. Ther. 2020;51:1434–1437. doi: 10.1111/apt.15777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lewiecki EM. Vitamin D and COVID-19: Is something better than nothing? Osteoporosis Sarcopenia. 2020 doi: 10.1016/j.afos.2020.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.